Meng Xu‐Welliver

Papers

Total Citations

H-Index

About

Meng Xu‐Welliver is a leading radiation oncologist whose research focuses on lung cancer, stereotactic body radiation therapy (SBRT), and the integration of advanced imaging to improve treatment precision. Her most cited work, "Cancer of the Lung" (2020, 42 citations), provides a comprehensive overview of modern management strategies, highlighting her expertise in bridging clinical practice with emerging technologies. Xu‐Welliver has made significant contributions to optimizing SBRT for early-stage lung cancer, demonstrating how dose escalation and motion management can enhance tumor control while minimizing toxicity. Her impact is reflected in her role as a principal investigator in multi-institutional trials and her authorship of guidelines that shape standard-of-care protocols. Notably, she has been recognized with awards for her mentorship and translational research, advancing personalized radiotherapy approaches. Xu‐Welliver’s work continues to influence how clinicians balance efficacy and safety in thoracic oncology, making her a key voice in the field.